ANGO - AngioDynamics • Financials

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Dividend	Payout	DY
05/2017	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
05/2018	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
05/2019	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
05/2020	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
05/2021	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
05/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
05/2023	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
05/2024	304	-165	-	L	L	206	L	-76	-	-39	-11	-64	-49	0	0	-	-
05/2025	292	-14	-	L	L	183	L	-56	-	-20	-10	-0	-30	-2	0	-	-
05/2026	320	-17	-	L	L	171	L	-54	-	-11	-6	1	-17	0	0	-	-

To see all financials—including updated, you must be Premium.